Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
- 1 July 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in AIDS
- Vol. 13 (10) , 1187-1193
- https://doi.org/10.1097/00002030-199907090-00006
Abstract
Evaluation of immunological reconstitution after 2 years of highly active antiretroviral therapy (HAART) in AIDS patients. Previous data showed the effectiveness of HAART but conflicting evidence of immune reconstitution has been found in severely immunocompromised patients. Therefore, T-cell subsets and functions were analysed during 24 months of HAART in 21 AIDS patients (mean baseline CD4 cell count, 20¥106/l). Subjects were tested at baseline and after 4, 12 and 24 months of therapy for clinical symptoms and the following investigations were carried out: plasma HIV RNA, T-cell subsets and lymphoproliferative responses to mitogens (phytohaemagglutinin, anti-CD3), and recall antigens (Candida mannoprotein, tetanus toxoid and recombinant glycoprotein 160). Increase in body weight, improvement of Karnofsky‚s score and reduction of opportunistic infections were observed. All patients showed an initial increase in the CD4 memory subset, whereas naive CD4 cells consistently increased only after 1 year. The magnitude of immune recovery was stronger in patients showing a significant reduction in viral load. However seven out of 21 patients who did not reach a sustained suppression of viral load showed also an increase in T-cell subsets. The majority of patients recovered lymphoproliferative responses to mitogens, whereas only four subjects showed a functional response to Candida mannoprotein. No patients showed a response to HIV recombinant glycoprotein 160 or tetanus toxoid. The immune recovery observed is slower and not complete in severely immunocompromised patients. Our data suggest that HAART may be continued also in the absence of a significant HIV RNA decrease if alternative drugs are not available.Keywords
This publication has 22 references indexed in Scilit:
- Changes in CD4+and CD8+T Cell Subsets in Response to Highly Active Antiretroviral Therapy in HIV Type 1-Infected Patients with Prior Protease Inhibitor ExperienceAIDS Research and Human Retroviruses, 1998
- Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adultsAIDS, 1998
- Long‐Term Evaluation of Cellular Immunity during Antiretroviral Therapy and Immunization with Human Immunodeficiency Virus Type 1 (HIV‐1) Env Glycoprotein in HIV‐1‐Infected PersonsThe Journal of Infectious Diseases, 1997
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Effect of Immunization With an Inactivated gp120-Depleted HIV-1 Immunogen on β-Chemokine and Cytokine Production in Subjects With HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- CD4+ cell turnoverNature, 1995
- CD4+ cell turnoverNature, 1995
- Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.Journal of Clinical Investigation, 1989
- T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort studyClinical Immunology and Immunopathology, 1989